Related Experiment Video

Updated: Jul 19, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Therapeutic targeting of apoptotic pathways in cancer

Johannes Meiler1, Martin Schuler

  • 1Department of Medicine III, Johannes Gutenberg University, Langenbeckstrasse 1, D-55131 Mainz, Germany.

Current Drug Targets
|November 1, 2006
PubMed

Insights

Cancer cells evade programmed cell death (apoptosis) to survive and resist therapy. Understanding apoptosis pathways is key to developing new cancer treatments that target this essential cell death mechanism.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Programmed cell death, or apoptosis, is a critical tumor suppressor mechanism.
  • Cancer cells frequently develop strategies to evade apoptosis, contributing to malignant transformation, tumor progression, and therapeutic resistance.
  • Defects in apoptotic pathways are a hallmark of many cancers.

Purpose of the Study:

  • To review the current understanding of apoptotic signal transduction pathways.
  • To discuss strategies for therapeutic modulation of apoptosis in cancer treatment.
  • To highlight the relevance of apoptosis in lymphoma and other cancers.

Main Methods:

  • Review of current scientific literature on apoptosis.
  • Analysis of molecular pathways involved in apoptotic signaling.
  • Examination of therapeutic strategies targeting apoptosis.

Main Results:

  • Significant progress has been made in delineating the molecular pathways of apoptosis.
  • Identification of molecular targets and lead compounds for novel cancer therapies.
  • Apoptosis evasion is a common feature enabling cancer progression and therapy resistance.

Conclusions:

  • Targeting apoptotic pathways offers a promising strategy for developing novel cancer therapies.
  • Understanding apoptosis is crucial for overcoming therapeutic resistance in lymphoma and other cancers.
  • Further research into apoptotic signal transduction can lead to more effective cancer treatments.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...